Karampli E, Souliotis K, Polyzos N, Kyriopoulos J, Chatzaki E
Department of Health Economics, National School of Public Health, Athens, Greece ; Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Faculty of Social Sciences, University of Peloponnese, Corinth, Greece.
Hippokratia. 2014 Apr;18(2):100-6.
Over the recent decades, advances in healthcare technology have led to significant improvements in the quality of healthcare and in population health. At the same time, technological change in healthcare, rising national income and expansion of insurance coverage have been acknowledged as the main determinants of the historical growth in health spending in industrialized countries. The pharmaceutical sector is of particular interest as it constitutes a market characterized by rapid technological change and high expenditure growth rates. The purpose of this article is to provide an overview of research findings on the impact of pharmaceutical innovation on pharmaceutical expenditure growth, total health expenditure and population health outcomes and to bring forward the challenges that arise for pharmaceutical policy in Greece.
在最近几十年里，医疗技术的进步已使医疗保健质量和人口健康状况得到显著改善。与此同时，医疗保健领域的技术变革、国民收入的增长以及保险覆盖范围的扩大，已被公认为工业化国家医疗支出历史增长的主要决定因素。制药行业尤其引人关注，因为它构成了一个以技术变革迅速和支出增长率高为特征的市场。本文旨在概述有关药物创新对药品支出增长、总体医疗支出和人口健康结果影响的研究发现，并提出希腊制药政策面临的挑战。
